Search
for
Sort by
Research 601–630 of 1000+
- Pharmacologic interventions in aging hair
- Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management
- Dihydrotestosteron und die Rolle der 5α-Reduktasehemmer bei der benignen Prostatahyperplasie
- Progesterone in gender-affirming therapy of trans women
- Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin
- Sex Hormones and Hair Loss in Men From the General Population of Northeastern Germany.
- Polycystic ovary syndrome: Challenges in adolescence
- Biotechs target stagnant baldness market
- The SH-1 Molecule By Dr. Melvin Sewell
- The SH-1 Molecule By Dr. Melvin Sewell
- Pharmacological inhibition of 5α-reductase in androgenetic alopecia: a comparative narrative review of finasteride and dutasteride, with attention to responder heterogeneity and female pattern hair loss
- Minoxidil May be a Partial Agonist of Estrogen Receptor Alpha
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- Implications of Non-compliance in the Management of Chronic Polycystic Ovarian Syndrome
- Fundamentals
- [Clinical significance of testosterone and dihydrotestosterone metabolism in women].
- [Hirsutism].
- Female pattern hair loss
- Does Cyclosporin A Influence Sex Hormone Level?
- Hair loss is an important symptom of the menopause
- Female pattern hair loss
- A case series of 20 women with hidradenitis suppurativa treated with spironolactone
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- Female Pattern Hair Loss
- Female pattern hair loss
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Proscar@ (Finasteride) inhibits 5α-reductase activity in the ovaries and testes of Lytechinus variegatus Lamarck (Echinodermata: Echinoidea)
- Effect of flutamide and two novel synthetic steroids on GABA, glutamine and some oxidative stress markers in rat brain and prostate
- Therapeutic Potentiality of Celtis choseniana Nakai on Androgenic Alopecia through Repression of Androgen Action and Modulation of Wnt/β-catenin Signaling
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology